IFPMA expands Code of practice

Friday 2 March 2012

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has announced an expansion of its Code of practice to govern how companies interact with healthcare professionals, medical institutions and patient organisations.

IFPMA represents the research-based pharmaceutical industry with its 1.3m employees. It requires all member companies and member associations around the world to adopt and implement the new code.

The code includes guiding principles for practice, a requirement for member companies to train all employees, a clear distinction between gifts, promotional aids and items of medical utility, guidance for supporting continuing medical education, a provision on disclosure of clinical trials information, and guidance for filing complaints.

It continues to prohibit preapproval promotional activities for pharmaceutical products, company-sponsored entertainment at events, and providing or offering personal gifts to healthcare professionals.

IFPMA has called on physicians, nurses, and other companies to ensure adherence to equally high standards of practice throughout the healthcare sector.

'The new code provides a framework for the industry to act with integrity and build trust,' said IFPMA president and AstraZeneca chief executive David Brennan.

The Prescription Medicines Code of Practice Authority, which is responsible for the Association of the British Pharmaceutical Industry's code, was involved with the changes to the IFPMA guidance. It is looking into how the changes may impact upon the ABPI Code.

Your page is loading. Please wait...